Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11778) 11778
Newsletter (56) 56
Magazine Article (23) 23
Book Chapter (21) 21
Conference Proceeding (6) 6
Newspaper Article (5) 5
Web Resource (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11358) 11358
rituximab (9631) 9631
science & technology (9136) 9136
life sciences & biomedicine (8970) 8970
female (5993) 5993
male (5739) 5739
antibodies, monoclonal, murine-derived (5647) 5647
middle aged (4729) 4729
adult (3852) 3852
antibodies, monoclonal - therapeutic use (3697) 3697
aged (3688) 3688
antibodies, monoclonal, murine-derived - therapeutic use (3282) 3282
treatment outcome (3181) 3181
biological and medical sciences (2840) 2840
hematology (2784) 2784
medical sciences (2784) 2784
oncology (2588) 2588
antineoplastic combined chemotherapy protocols - therapeutic use (2570) 2570
antibodies, monoclonal, murine-derived - administration & dosage (1893) 1893
antineoplastic agents - therapeutic use (1789) 1789
antibodies, monoclonal - administration & dosage (1644) 1644
aged, 80 and over (1477) 1477
immunologic factors - therapeutic use (1469) 1469
cyclophosphamide - administration & dosage (1422) 1422
animals (1396) 1396
hematologic and hematopoietic diseases (1358) 1358
lymphoma, large b-cell, diffuse - drug therapy (1318) 1318
abridged index medicus (1227) 1227
prognosis (1146) 1146
antineoplastic combined chemotherapy protocols - administration & dosage (1143) 1143
vincristine - administration & dosage (1139) 1139
retrospective studies (1119) 1119
cyclophosphamide - therapeutic use (1088) 1088
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (1087) 1087
doxorubicin - administration & dosage (1079) 1079
antibodies, monoclonal, murine-derived - adverse effects (1041) 1041
antineoplastic agents (1040) 1040
remission induction (999) 999
care and treatment (998) 998
prednisone - administration & dosage (991) 991
immunology (984) 984
rheumatology (983) 983
adolescent (974) 974
antibodies, monoclonal - adverse effects (970) 970
immunosuppressive agents - therapeutic use (961) 961
young adult (925) 925
cancer (919) 919
mice (919) 919
pharmacology. drug treatments (888) 888
prednisone - therapeutic use (887) 887
lymphomas (886) 886
disease-free survival (857) 857
recurrence (826) 826
chemotherapy (820) 820
medicine & public health (820) 820
lymphoma (813) 813
vincristine - therapeutic use (801) 801
immunotherapy (799) 799
follow-up studies (781) 781
doxorubicin - therapeutic use (773) 773
antigens, cd20 - immunology (755) 755
lymphoma, b-cell - drug therapy (749) 749
transplantation (730) 730
b-lymphocytes - immunology (725) 725
monoclonal antibodies (710) 710
lymphoma, non-hodgkin - drug therapy (662) 662
combined modality therapy (658) 658
antirheumatic agents - therapeutic use (657) 657
drug therapy (657) 657
drug therapy, combination (654) 654
antineoplastic combined chemotherapy protocols - adverse effects (629) 629
time factors (625) 625
antineoplastic agents - administration & dosage (619) 619
tumors (610) 610
general & internal medicine (609) 609
lymphoma, large b-cell, diffuse - pathology (598) 598
medicine, general & internal (586) 586
immunohistochemistry (573) 573
arthritis, rheumatoid - drug therapy (563) 563
lymphoma, follicular - drug therapy (562) 562
child (561) 561
risk factors (553) 553
antibodies, monoclonal - pharmacology (535) 535
analysis (534) 534
antineoplastic agents - adverse effects (534) 534
research (531) 531
antimitotic agents (529) 529
b-lymphocytes - drug effects (528) 528
drug administration schedule (528) 528
leukemia, lymphocytic, chronic, b-cell - drug therapy (523) 523
hemic and lymphatic diseases (519) 519
health aspects (497) 497
cyclophosphamide (480) 480
antibodies, monoclonal, murine-derived - pharmacology (474) 474
neoplasm staging (471) 471
survival analysis (470) 470
clinical trials as topic (447) 447
survival rate (440) 440
antibodies (439) 439
antibodies, monoclonal, murine-derived - immunology (430) 430
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11085) 11085
Japanese (355) 355
French (176) 176
Chinese (158) 158
German (146) 146
Spanish (124) 124
Russian (55) 55
Italian (30) 30
Portuguese (24) 24
Hungarian (23) 23
Polish (21) 21
Czech (15) 15
Danish (15) 15
Croatian (11) 11
Dutch (9) 9
Norwegian (8) 8
Finnish (7) 7
Hebrew (7) 7
Korean (4) 4
Serbian (3) 3
Romanian (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Management of noninfectious mixed cryoglobulinemia vasculitis: Data from 242 cases included in the CryoVas survey
by Terrier, Benjamin and Krastinova, Evguenia and Marie, Isabelle and Launay, David and Lacraz, Adeline and Belenotti, Pauline and De Saint-Martin, Luc and Quemeneur, Thomas and Huart, Antoine and Bonnet, Fabrice and Le Guenno, Guillaume and Kahn, Jean-Emmanuel and Hinschberger, Olivier and Rullier, Patricia and Diot, Elisabeth and Lazaro, Estibaliz and Bridoux, Frank and Zénone, Thierry and Carrat, Fabrice and Hermine, Olivier and Léger, Jean-Marc and Mariette, Xavier and Senet, Patricia and Plaisier, Emmanuelle and Cacoub, Patrice
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 25, pp. 5996 - 6004
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Infection - therapy | Vasculitis - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Data Collection | Cryoglobulinemia - complications | Vasculitis - complications | Cryoglobulinemia - epidemiology | Infection - epidemiology | Female | Retrospective Studies | Vasculitis - therapy | Cryoglobulinemia - therapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Adrenal Cortex Hormones - adverse effects | Algorithms | Antibodies, Monoclonal - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Infection - complications | Adrenal Cortex Hormones - administration & dosage | Cohort Studies | Index Medicus | Abridged Index Medicus | Cryoglobulinemia | Antibodies, Monoclonal, Murine-Derived | Adrenal Cortex Hormones | Antibodies, Monoclonal | Infection | Life Sciences | Vasculitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia
by Kowalczyk-Quintas, Christine and Willen, Laure and Dang, Anh Thu and Sarrasin, Heidi and Tardivel, Aubry and Hermes, Katharina and Schneider, Holm and Gaide, Olivier and Donzé, Olivier and Kirby, Neil and Headon, Denis J and Schneider, Pascal
The Journal of biological chemistry, ISSN 0021-9258, 02/2014, Volume 289, Issue 7, pp. 4273 - 4285
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Humans | Ectodysplasins - metabolism | Ectodysplasins - immunology | Molecular Sequence Data | Male | Antibodies, Monoclonal, Murine-Derived - toxicity | Antibodies, Neutralizing - immunology | Ectodermal Dysplasia - metabolism | Cattle | Mice, Mutant Strains | Base Sequence | Ectodermal Dysplasia - pathology | Female | Cell Line | Antibodies, Monoclonal, Murine-Derived - immunology | Ectodysplasins - genetics | Ectodermal Dysplasia - immunology | Antibodies, Neutralizing - genetics | Ectodermal Dysplasia - chemically induced | Pregnancy | Autoantibodies - immunology | Animals | Autoantibodies - toxicity | Dogs | Ectodysplasins - antagonists & inhibitors | Ectodermal Dysplasia - genetics | Mice | Antibodies, Monoclonal, Murine-Derived - genetics | Autoantibodies - genetics | Antibodies, Neutralizing - toxicity | Index Medicus | Antibodies | Embryo | Receptors | Tooth | Developmental Biology | Tumor Necrosis Factor (TNF)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Neutrophils mediate antibody-induced antitumor effects in mice
by Albanesi, Marcello and Albanesi, Marcello and Mancardi, David A and Mancardi, David A and Jönsson, Friederike and Jönsson, Friederike and Iannascoli, Bruno and Iannascoli, Bruno and Fiette, Laurence and Fiette, Laurence and Di Santo, James P and Di Santo, James P and Lowell, Clifford A and Lowell, Clifford A and Bruhns, Pierre and Bruhns, Pierre
Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 18, pp. 3160 - 3164
Life Sciences & Biomedicine | Hematology | Science & Technology | Breast Neoplasms - immunology | Humans | Melanoma, Experimental - drug therapy | Antibody-Dependent Cell Cytotoxicity - immunology | Receptors, IgG - metabolism | Receptors, IgG - genetics | Melanoma, Experimental - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Neutrophils - metabolism | Antibodies, Monoclonal - immunology | Antibody-Dependent Cell Cytotoxicity - genetics | Antibodies, Monoclonal, Murine-Derived - immunology | Antibodies, Monoclonal - pharmacology | Mice, Inbred C57BL | Neutrophils - drug effects | Neutrophils - immunology | Rituximab | Mice, Transgenic | Receptors, IgG - immunology | Breast Neoplasms - drug therapy | Mice, Knockout | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Melanoma, Experimental - genetics | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Mice | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal, Murine-Derived - pharmacology | Antibody-Dependent Cell Cytotoxicity - drug effects | Trastuzumab | Tumor Burden - immunology | Index Medicus | Abridged Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity | Neutrophils | Antibodies, Monoclonal | Tumor Burden | Breast Neoplasms | Life Sciences | Receptors, IgG | Antibodies, Monoclonal, Humanized | Immunology | Melanoma, Experimental | Immunotherapy | 12 | 34 | Immunobiology | Brief Report | 6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
by Kohrt, Holbrook E and Houot, Roch and Goldstein, Matthew J and Weiskopf, Kipp and Alizadeh, Ash A and Brody, Josh and Müller, Antonia and Pachynski, Russell and Czerwinski, Debra and Coutre, Steven and Chao, Mark P and Chen, Lieping and Tedder, Thomas F and Levy, Ronald
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 8, pp. 2423 - 2432
Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD20 - immunology | Antibody-Dependent Cell Cytotoxicity | Antibodies, Monoclonal - pharmacology | Humans | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Rituximab | Antibodies, Monoclonal - therapeutic use | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Tumor Cells, Cultured | Antibodies, Monoclonal, Murine-Derived - pharmacology | Index Medicus | Abridged Index Medicus | Life Sciences | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Antibodies, Monoclonal | Antigens, CD137 | Cancer | Lymphoid Neoplasia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
by Trappe, Ralf, Dr and Oertel, Stephan, MD and Leblond, Veronique, Prof and Mollee, Peter, MBBS and Sender, Monica, MD and Reinke, Petra, Prof and Neuhaus, Ruth, MD and Lehmkuhl, Hans, MD and Horst, Heinz August, Prof and Salles, Gilles, Prof and Morschhauser, Franck, MD and Jaccard, Arnaud, Prof and Lamy, Thierry, Prof and Leithäuser, Malte, MD and Zimmermann, Heiner, MB BChir and Anagnostopoulos, Ioannis, Prof and Raphael, Martine, Prof and Riess, Hanno, Prof and Choquet, Sylvain, MD and the European PTLD Network and for the German PTLD Study Group and European PTLD Network and German PTLD Study Grp and German PTLD Study Group
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 196 - 206
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Organ Transplantation - pathology | Cyclophosphamide - therapeutic use | Epstein-Barr Virus Infections - therapy | Vincristine - administration & dosage | Adult | Female | Herpesvirus 4, Human - pathogenicity | Prednisolone - therapeutic use | France | Lymphoproliferative Disorders - etiology | Doxorubicin - administration & dosage | Antigens, CD20 - immunology | Rituximab | Lymphoproliferative Disorders - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organ Transplantation - adverse effects | Adolescent | Vincristine - therapeutic use | Epstein-Barr Virus Infections - diagnosis | Lymphoproliferative Disorders - drug therapy | Aged | Germany | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Organ transplant recipients | Clinical trials | Product development | Epstein-Barr virus | Universities and colleges | Prednisolone | Cancer | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Lymphoproliferative Disorders | Antineoplastic Combined Chemotherapy Protocols | Organ Transplantation | Vincristine | Doxorubicin | Herpesvirus 4, Human | Life Sciences | Immunology | Epstein-Barr Virus Infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody
by White, Ann L and Chan, H. T. Claude and Roghanian, Ali and French, Ruth R and Mockridge, C. Ian and Tutt, Alison L and Dixon, Sandra V and Ajona, Daniel and Verbeek, J. Sjef and Al-Shamkhani, Aymen and Cragg, Mark S and Beers, Stephen A and Glennie, Martin J
The Journal of immunology (1950), ISSN 0022-1767, 08/2011, Volume 187, Issue 4, pp. 1754 - 1763
Life Sciences & Biomedicine | Immunology | Science & Technology | Antibodies, Monoclonal, Murine-Derived - immunology | Antineoplastic Agents - immunology | Immunologic Capping - immunology | Antibodies, Monoclonal, Murine-Derived - pharmacokinetics | Rats | Receptors, IgG - immunology | Mice, Knockout | Signal Transduction - immunology | Animals | Signal Transduction - drug effects | Immunologic Capping - drug effects | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | CD40 Antigens - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody GA101
by Dalle, Stephane and Reslan, Lina and De Horts, Timothee Besseyre and Herveau, Stephanie and Herting, Frank and Plesa, Adriana and Friess, Thomas and Umana, Pablo and Klein, Christian and Dumontet, Charles
Molecular cancer therapeutics, ISSN 1535-7163, 01/2011, Volume 10, Issue 1, pp. 178 - 185
Life Sciences & Biomedicine | Oncology | Science & Technology | Antigens, CD20 - immunology | Dose-Response Relationship, Immunologic | Lymphoma, Follicular - drug therapy | Antibodies, Monoclonal - pharmacology | Humans | Rituximab | Gene Expression Profiling | Mice, SCID | Xenograft Model Antitumor Assays | Antibodies, Monoclonal, Humanized | Cyclophosphamide - blood | Antibodies, Monoclonal, Murine-Derived - blood | Animals | Lymphoma, Follicular - blood | Lymphoma, Follicular - genetics | Lymphoma, Follicular - immunology | Cyclophosphamide - pharmacology | Cell Line, Tumor | Female | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | Antibodies, Monoclonal - immunology | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Antibodies, Monoclonal | Life Sciences | Cyclophosphamide | Lymphoma, Follicular | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
by Specks, Ulrich and Merkel, Peter A and Seo, Philip and Spiera, Robert and Langford, Carol A and Hoffman, Gary S and Kallenberg, Cees G.M and St. Clair, E. William and Fessler, Barri J and Ding, Linna and Viviano, Lisa and Tchao, Nadia K and Phippard, Deborah J and Asare, Adam L and Lim, Noha and Ikle, David and Jepson, Brett and Brunetta, Paul and Allen, Nancy B and Fervenza, Fernando C and Geetha, Duvuru and Keogh, Karina and Kissin, Eugene Y and Monach, Paul A and Peikert, Tobias and Stegeman, Coen and Ytterberg, Steven R and Mueller, Mark and Sejismundo, Lourdes P and Mieras, Kathleen and Stone, John H and RAVE-ITN Res Grp and RAVE-ITN Research Group
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients
by Gobert, Delphine and Bussel, James B and Cunningham‐Rundles, Charlotte and Galicier, Lionel and Dechartres, Agnès and Berezne, Alice and Bonnotte, Bernard and DeRevel, Thierry and Auzary, Christophe and Jaussaud, Roland and Larroche, Claire and LeQuellec, Alain and Ruivard, Marc and Seve, Pascal and Smail, Amar and Viallard, Jean‐François and Godeau, Bertrand and Hermine, Olivier and Michel, Marc
British journal of haematology, ISSN 0007-1048, 11/2011, Volume 155, Issue 4, pp. 498 - 508
common variable immunodeficiency | autoimmune haemolytic anaemia | Evans’ syndrome | immune thrombocytopenia | rituximab | Rituximab | Autoimmune haemolytic anaemia | Common variable immunodeficiency | Immune thrombocytopenia | Evans' syndrome | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Immunopathology | Biological and medical sciences | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Common Variable Immunodeficiency - drug therapy | Humans | Middle Aged | Thrombocytopenia - immunology | Anemia, Hemolytic, Autoimmune - drug therapy | Male | Common Variable Immunodeficiency - blood | Young Adult | Thrombocytopenia - drug therapy | Anemia, Hemolytic, Autoimmune - immunology | Adolescent | Adult | Female | Aged | Retrospective Studies | Antibodies, Monoclonal, Murine-Derived - adverse effects | Child | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antimitotic agents | Medical colleges | Medical research | Immunoglobulins | Medicine, Experimental | Adults | Antineoplastic agents | Index Medicus | Thrombocytopenia | Antibodies, Monoclonal, Murine-Derived | Common Variable Immunodeficiency | Anemia, Hemolytic, Autoimmune | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights